Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation
The human voltage gated potassium channel Kv1.5 that conducts the I<sub>Kur</sub> current is a key determinant of the atrial action potential. Its mutations have been linked to hereditary forms of atrial fibrillation (AF), and the channel is an attractive target for the management of AF....
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/12/1303 |